TSHA- Taysha Gene Therapies, Inc.

Name: Taysha Gene Therapies, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

TSHA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Nolan Sean P.	3.09M	-	-
CFO	Alam Kamran	1.44M	$6.52M	-
Dir	Stalfort John A III	1.18M	-	-
Pres	Nagendran Sukumar	936.4K	$5.84M	-
Dir	Donenberg Phillip B.	241.3K	-	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 10, 2026	Nagendran Sukumar49	President And Head Of R&D	Sell	200,000	$6.24	$1,248,000.00	-17.6%	-	-
Apr 10, 2026	Nagendran Sukumar49	President And Head Of R&D	Sale+OE	200,000	$4.46	$892,000.00	-15.0%	-	-
Feb 4, 2026	Alam Kamran83	Chief Financial Officer	Sell	1,655	$4.52	$7,480.60	-0.1%	+52.9%	-
Jan 12, 2026	Nagendran Sukumar49	President And Head Of R&D	Sale+OE	200,000	$4.71	$942,000.00	-16.6%	-7.6%	-
Dec 1, 2025	Nagendran Sukumar49	President And Head Of R&D	Sale+OE	370,172	$4.58	$1,695,905.72	-26.9%	+2.3%	-
Sep 10, 2025	Nagendran Sukumar49	President And Head Of R&D	Sale+OE	200,000	$3.23	$646,000.00	-16.6%	+63.4%	-
Aug 21, 2025	Nagendran Sukumar49	President And Head Of R&D	Sell	57,054	$2.85	$162,603.90	-4.7%	+39.7%	-
Aug 21, 2025	Alam Kamran83	Chief Financial Officer	Sell	54,491	$2.85	$155,299.35	-4.4%	+39.7%	-
May 30, 2025	Manning Paul B54	10% Owner	Buy	750,000	$2.75	$2,062,500.00	+35.9%	+4.4%	+116.6%
Jun 27, 2024	Manning Paul B54	10% Owner	Buy	1,333,333	$2.25	$2,999,999.25	New	-7.2%	+9.9%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC